AJMC Roundtable: Evaluating the Management of Cancer Immunotherapy (CIT)ByStuart Genschaw, MBADecember 15th 2021Stuart Genschaw, MBA, discusses how his practice approaches cancer immunotherapy (CIT) management and the potential future pathways of care.